Viewing Study NCT03468556


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:28 PM
Study NCT ID: NCT03468556
Status: UNKNOWN
Last Update Posted: 2023-05-01
First Post: 2018-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis
Sponsor: Sinew Pharma Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-01
Start Date Type: ESTIMATED
Primary Completion Date: 2024-12-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2018-03-06
First Submit QC Date: None
Study First Post Date: 2018-03-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-28
Last Update Post Date: 2023-05-01
Last Update Post Date Type: ACTUAL